首页 | 本学科首页   官方微博 | 高级检索  
     

Act1作用的分子机制及其与免疫损伤性疾病关系的研究进展
引用本文:刘嫣方,王胜军,许化溪. Act1作用的分子机制及其与免疫损伤性疾病关系的研究进展[J]. 国际免疫学杂志, 2010, 33(4): 423-426,430. DOI: 10.3760/cma.j.issn.1673-4394.2010.06.003
作者姓名:刘嫣方  王胜军  许化溪
作者单位:江苏大学基础医学与医学技术学院,镇江,212013;
基金项目:国家自然科学基金江苏大学大学生科技创新项目
摘    要:T and B cell-mediated immune responses play a critical role in the control and modulation of autoimmune diseases. NF-kappa B Activator 1 (Act1) , also called (connection to Iκ B kinase and stress-activated protein kinases,CIKS), is a recently identified molecule, which activates NF-κB . Recent studies have shown that Act1 is a key positive regulator of IL-17 signaling pathway ,and an important negative regulator of B cell-mediated humeral immune responses through its function in CD40L and BAFF signaling. Act1 is critical for TH17 and B cell mediated autoimmune and inflammatory responses. Moreover, Actl may play important roles in ontogenesis. Such seemingly opposite functions of Act1 in CD40-BAFFR and IL-17R signaling are orchestrated by different domains in Act1. Such delicate regulatory mechanisms may provide a common vehicle to promote balance between host defense to pathogens and tolerance to self.

关 键 词:免疫损伤性疾病   

Progress in researches of molecular mechanism of Act1 and its role in autoimmune diseases
LIU Yan-fang,WANG Sheng-jun,XU Hua-xi. Progress in researches of molecular mechanism of Act1 and its role in autoimmune diseases[J]. International Journal of Immunology, 2010, 33(4): 423-426,430. DOI: 10.3760/cma.j.issn.1673-4394.2010.06.003
Authors:LIU Yan-fang  WANG Sheng-jun  XU Hua-xi
Abstract:
Keywords:Act1IL-17CD40L-BAFFAct1IL-17CD40L-BAFFAutoimmune and inflammatory responses
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号